Bilaketaren emaitzak

Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity nork C.‐K. HWANG, G. Baker Hubbard, Amy K. Hutchinson, Scott R. Lambert

Testu osoa

Prognostic and predictive response factors in colorectal cancer patients: Between hope and reality nork Chiara De Divitiis

Testu osoa

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration nork Daniel F Martin, Maureen G. Maguire, Gui‐Shuang Ying, Juan E. Grunwald, Stuart L. Fine, Glenn J. Jaffe

Testu osoa Testu osoa

Human epidermal receptor 2–amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti–vascular endothelial growth factor combination tre... nork Gerald S. Falchook, Scott M. Lippman, Christel C. Bastida, Razelle Kurzrock

Testu osoa

Efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and... nork Yukihiko Hiroshima, Yong Zhang, Takashi Murakami, Ali Maawy, Shinji Miwa, Mako Yamamoto, Shuya Yano, Sho Sato, Masashi Momiyama, Rintaro Mori, Ryusei Matsuyama, Takashi Chishima, Kuniya Tanaka, Yasushi Ichikawa, Michael Bouvet, Itaru Endo, Ming Zhao, Robert M. Hoffman

Testu osoa Testu osoa

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration nork Daniel Martín, Maureen G. Maguire, Stuart L. Fine, Gui‐shuang Ying, Glenn J. Jaffe, Juan E. Grunwald, Cynthia A. Toth, Maryann Redford, Frederick L. Ferris

Testu osoa

Interleukin‐18 Has Antipermeablity and Antiangiogenic Activities in the Eye: Reciprocal Suppression With VEGF nork Jikui Shen, David F. Choy, Tsunehiko Yoshida, Takeshi Iwase, Gulnar Hafiz, Bing Xie, Sean F. Hackett, Joseph R. Arron, Peter A. Campochiaro

Testu osoa

Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis nork Daniel Escorsim Machado, Jamila Alessandra Perini, Margarida Maria Camões Orlando, Ralph Santos‐Oliveira

Testu osoa Testu osoa

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high‐risk localized prostate cancer nork Robert W. Ross, Matthew D. Galsky, Phil Febbo, Marc Barry, Jerome P. Richie, Wanling Xie, Fiona M. Fennessy, Rupal S. Bhatt, J. D. Hayes, Toni K. Choueiri, Clare M. Tempany, Philip W. Kantoff, Mary Ellen Taplin, William Oh

Testu osoa Testu osoa

Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study nork Jeffrey R. Infante, Tony R. Reid, Allen Lee Cohn, William J. Edenfield, Terrence P. Cescon, John Hamm, Imtiaz A. Malik, Thomas A. Rado, Philip J. McGee, Donald Richards, Jamal Tarazi, Brad Rosbrook, Sinil Kim, Thomas H. Cartwright

Testu osoa Testu osoa

The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery nork Daniel C. Cochran, Michael D. Chan, Mebea Aklilu, James Lovato, Natalie K. Alphonse, J. Daniel Bourland, James J. Urbanic, Kevin P. McMullen, Edward G. Shaw, Stephen B. Tatter, Thomas L. Ellis

Testu osoa

Macular edema post-LASIK treated with ranibizumab nork Luiz Guilherme Azevedo de Freitas, Natália Silva de Mesquita, Juliana Aquino Teixeira Zorrilla, Marcos Pereira de Ávila

Testu osoa Testu osoa

Targeted Therapies in Triple-Negative Breast Cancer nork Frederik Marmé, Andreas Schneeweiß

Testu osoa Testu osoa

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group nork Jubilee Brown, William E. Brady, Julian C. Schink, Linda Van Le, Mario M. Leitão, S. Diane Yamada, Koen De Geest, David M. Gershenson

Testu osoa Testu osoa

A phase 2 study of bevacizumab with cisplatin plus intensity‐modulated radiation therapy for stage III/IVB head and neck squamous cell cancer nork Matthew G. Fury, Nancy Y. Lee, Eric J. Sherman, Donna Lisa, Katherine W. Kelly, Brynna Lipson, Diane L. Carlson, Hilda E. Stambuk, Sofia Haque, Ronglai Shen, Dennis H. Kraus, Jatin P. Shah, David G. Pfister

Testu osoa Testu osoa

Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma nork Petros Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler, Robert Dreicer, Manish Kohli, Daniel P. Petrylak, David J. Vaughn, Kathryn Bylow, Steven Wong, Joseph L. Sottnik, Evan T. Keller, Mahmoud Al‐Hawary, David C. Smith, Maha Hussain

Testu osoa Testu osoa

Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases nork Lisa Volk, Michael J. Flister, Deena B. Chihade, Neil Desai, Vuong Trieu, Sophia Ran

Testu osoa

Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer nork Philip A. Philip, Michelle R. Mahoney, Kyle D. Holen, Donald W. Northfelt, Henry C. Pitot, Joel Picus, Patrick J. Flynn, Charles Erlichman

Testu osoa

Recent advances in the treatment of metastatic renal cell carcinoma nork Hideyuki Abe, Takao Kamai

Testu osoa

NRG Oncology<i>/</i>RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel fo... nork Akila N. Viswanathan, Jennifer Moughan, Brigitte Miller, Ying Xiao, Anuja Jhingran, Lorraine Portelance, Walter Bosch, Ursula A. Matulonis, Neil S. Horowitz, Robert S. Mannel, Luís Souhami, Bradley A. Erickson, Kathryn Winter, William Small, David K. Gaffney

Testu osoa Testu osoa